Financial Results for the period ended 31.03.2025
Awaiting price reaction for this filing.
Solana Biofuels reported audited results for FY25 with total revenue from operations of ₹14,741.67 lakhs, more than doubling from ₹6,732.85 lakhs in FY24 (about 119% growth), driven mainly by the Bio Diesel segment. Despite strong top-line growth, the company posted a net loss of ₹111.12 lakhs for the year, though this was a sharp improvement from a ₹724.30 lakh loss last year. Loss before tax narrowed to ₹175.54 lakhs vs ₹724.30 lakhs, and EPS improved to ₹(0.25) from ₹(1.61). The balance sheet shows total borrowings of about ₹17,103 lakhs against equity of only ₹3,660 lakhs (other equity is negative at ₹(840) lakhs), indicating very high leverage. Cash flow from operations turned positive at ₹126.65 lakhs (vs negative ₹1,140 lakhs last year), supported by heavy new borrowings and continued capex of ₹2,890 lakhs into capital work-in-progress.
For shareholders, the doubling of revenue and narrowing of losses are positives, but the company remains loss-making with deeply negative other equity and very high debt (D/E ratio above 4x). This keeps the stock speculative; near-term movement may depend on whether the Bio Diesel margin expansion translates into sustained profitability and debt reduction.